Literature DB >> 17804513

Affinity thresholds for membrane fusion triggering by viral glycoproteins.

Kosei Hasegawa1, Chunling Hu, Takafumi Nakamura, James D Marks, Stephen J Russell, Kah-Whye Peng.   

Abstract

Enveloped viruses trigger membrane fusion to gain entry into cells. The receptor affinities of their attachment proteins vary greatly, from 10(-4) M to 10(-9) M, but the significance of this is unknown. Using six retargeted measles viruses that bind to Her-2/neu with a 5-log range in affinity, we show that receptor affinity has little impact on viral attachment but is nevertheless a key determinant of infectivity and intercellular fusion. For a given cell surface receptor density, there is an affinity threshold above which cell-cell fusion proceeds efficiently. Suprathreshold affinities do not further enhance the efficiency of membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804513      PMCID: PMC2169077          DOI: 10.1128/JVI.01415-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  HIV-1 attachment: another look.

Authors:  S Ugolini; I Mondor; Q J Sattentau
Journal:  Trends Microbiol       Date:  1999-04       Impact factor: 17.079

Review 2.  Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor.

Authors:  H Meden; W Kuhn
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1997-02       Impact factor: 2.435

Review 3.  Recognition at the cell surface: recent structural insights.

Authors:  D I Stuart; E Y Jones
Journal:  Curr Opin Struct Biol       Date:  1995-12       Impact factor: 6.809

4.  Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.

Authors:  R Schier; A McCall; G P Adams; K W Marshall; H Merritt; M Yim; R S Crawford; L M Weiner; C Marks; J D Marks
Journal:  J Mol Biol       Date:  1996-11-08       Impact factor: 5.469

5.  In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.

Authors:  R Schier; J D Marks; E J Wolf; G Apell; C Wong; J E McCartney; M A Bookman; J S Huston; L L Houston; L M Weiner
Journal:  Immunotechnology       Date:  1995-05

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  The human CD46 molecule is a receptor for measles virus (Edmonston strain).

Authors:  R E Dörig; A Marcil; A Chopra; C D Richardson
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.

Authors:  D Naniche; G Varior-Krishnan; F Cervoni; T F Wild; B Rossi; C Rabourdin-Combe; D Gerlier
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor.

Authors:  D K Takemoto; J J Skehel; D C Wiley
Journal:  Virology       Date:  1996-03-15       Impact factor: 3.616

10.  Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.

Authors:  P G Natali; M R Nicotra; A Bigotti; I Venturo; D J Slamon; B M Fendly; A Ullrich
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

View more
  42 in total

1.  Oncolytic measles virus retargeting by ligand display.

Authors:  Pavlos Msaouel; Ianko D Iankov; Cory Allen; Stephen J Russell; Evanthia Galanis
Journal:  Methods Mol Biol       Date:  2012

2.  Targeting adenoviruses with factor x-single-chain antibody fusion proteins.

Authors:  Christopher Y Chen; Shannon M May; Michael A Barry
Journal:  Hum Gene Ther       Date:  2010-06       Impact factor: 5.695

3.  DARPins: an efficient targeting domain for lentiviral vectors.

Authors:  Robert C Münch; Michael D Mühlebach; Thomas Schaser; Sabrina Kneissl; Christian Jost; Andreas Plückthun; Klaus Cichutek; Christian J Buchholz
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

Review 4.  Attenuated oncolytic measles virus strains as cancer therapeutics.

Authors:  P Msaouel; I D Iankov; A Dispenzieri; E Galanis
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

5.  Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13.

Authors:  Wu Ou; Michael P Marino; Akiko Suzuki; Bharat Joshi; Syed R Husain; Andrea Maisner; Evanthia Galanis; Raj K Puri; Jakob Reiser
Journal:  Hum Gene Ther Methods       Date:  2012-05-21       Impact factor: 2.396

6.  DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

Authors:  Katrin Friedrich; Jan Rh Hanauer; Steffen Prüfer; Robert C Münch; Iris Völker; Christodoulos Filippis; Christian Jost; Kay-Martin Hanschmann; Roberto Cattaneo; Kah-Whye Peng; Andreas Plückthun; Christian J Buchholz; Klaus Cichutek; Michael D Mühlebach
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

7.  Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection.

Authors:  Arlene Barlan; Jincun Zhao; Mayukh K Sarkar; Kun Li; Paul B McCray; Stanley Perlman; Tom Gallagher
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters.

Authors:  Shumpei Watanabe; Yuta Shirogane; Satoshi O Suzuki; Satoshi Ikegame; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo.

Authors:  Hooi Tin Ong; Theodore R Trejo; Linh D Pham; Ann L Oberg; Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 10.  Oncolytic measles virus strains as novel anticancer agents.

Authors:  Pavlos Msaouel; Mateusz Opyrchal; Evidio Domingo Musibay; Evanthia Galanis
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.